The research report on the global and China OTC drug and dietary supplement market examines the scenario with the aid of descriptive overviews and key market data. The report explains the industry’s overall capabilities, growth rate, and infrastructure of manufacturing and distribution systems in use. It also elaborates on the major avenues of growth, as well as restraints on the OTC drug and dietary supplement market. Growing health concerns and advancements in the medical fields are a few of the driving factors for this market. The report focuses on common and unique consumer health trends while segmenting the data based on market size, scope of growth, and geographical regions, while using a detailed analysis on the markets in China, the U.S., and Europe.
The research report investigates statistics from current, recent, and historical directories, to provide forecasts of the market’s size and rate of productivity. A wide spectrum of information organized in an accessible method makes for an easy-to-understand market analysis. The research report also uses Porter’s five forces model analysis, SWOT analysis, and a value-chain assessment that will help you stay at the top with the projected opportunities and competition in the OTC drug and dietary supplements market.
Overview of the OTC drug and dietary supplement market
Over the Counter or OTC drugs are those that do not require a prescription to be purchased. The global and China OTC drug and dietary supplement market consists of all drugs that are related to minor ailments, along with dietary supplements that are FDA approved for regular and normal consumption. All products in the OTC drug and dietary supplement market are assessed by the FDA’s Research Office of Drug Evaluation IV and the Center for Drug Evaluation.
A key driving factor for the OTC drug and dietary supplement market is an increase in the number of adult population preferring to buy OTC drugs for minor ailments without prior visitations to a doctor. The easy availability of medical data and counsel over the Internet has enabled many consumers to gain more knowledge of the medical market, allowing them to take minor decisions about their health by themselves. The primary segments for the OTC drug market are analgesics, dermatologicals, and digestive remedies. The drugs that usually top sales in the OTC drug and dietary supplements market are cough and cold medicines, painkillers, heartburn remedies, laxatives, oral antiseptics, eye care solutions, anti-smoking products, and nutrition aids. Other minor areas of sales include antidiarrheals, sunscreens, anti-itch topical analgesics, and first-aid equipment.
The key players involved in the OTC drug and dietary supplement market are Pfizer, Sun Pharma, Novartis, Proctor and Gamble, GlaxoSmithKline, and Bayer.
Major geographies analyzed under this research report are:
- North America
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements in the OTC drug and dietary supplement market
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.